1Samal B, Sun Y, Stearn G, et al. Cloning and characterization of the cDNA encoding a novel human pre B-cell colony-enhancing factor[J]. Mol Cell Biol, 1994, 14 (2):1431-1437.
2Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin[J]. Science, 2005, 307(5708): 426-430.
3Curat CA, Wegner V, Sengenes C, et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin[J]. Diabetologia, 2006, 49(4) :744-747.
4Ognjanovic S, Bao S, Yamamoto SY, et al. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes [J]. J Mol Endoerinol, 2001, 26(2): 107-117.
5Kitani T, Okuno S, Fujisawa H. Growth phase-depen-dent changes in the subcellular localization of pre-Bcell colony-enhancing factor[J]. FEBS Lett, 2003, 544(1/3): 74-78.
6Hug G, Lodish HF. Visfatin:a new adipokine[J]. Science, 2005, 307(5708):366-367.
7Bae SK, Kim SR, Kim JG, et al. Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1[J]. FEBSLett, 2006, 580(17): 4105-4113.
8Segawa K, Fukuhara A, Hosogai N, et al. Visfatin in ad- ipocytes is upregulated by hypoxia through HIFlalpha-dependent mechanism[J]. Biochem Biophys Res Commun, 2006, 349(3): 875- 882.
9Dahl TB, Yndestad A, Skjelland M, et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis possible role in inflammation and plaque destabilization[J~. Circulation, 2007, 115(8) : 972-980.
10Adya R, Tan BK, Chen J, et al. Nuclear factor-kappaB induction by visfatin in human vascular endothelial cells:Its role in MMP-2/9 production and activation[J]. Diabetes Care, 2008, 31 (4):758-760.
4Braunwald E,Antman EM,Beasley JW,et al.ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction.A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol,2000,36(3):970-1062.
5冯新成.替罗非班对急性冠脉综合征患者炎症因子的影响.医药与保健,2009,:220-221.
6Adya R,Tan BK,Chen J,et al.Nuclear factor-kappaB induction by visfatin in human vascular endothelial cells:Its role in MMP-2/9 production and activation[J].Diabetes Care,2008,31(4):758-760.
7Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin : a pro- tein secreted by visceral fat that mimics the effects of insulin [ J]. Science ,2005,307 (5708) :426 - 430.
8Dahl TB, Yndestad A, Skjelland M, et al. Increased expres- sion of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization [ J ]. Circulation ,2007,115 ( 8 ) :972.
9Curat CA, Wegner V, Sengen s C, et al. Macrophages in hu-man viaceral adipose tissue:increased accumulation in obesi- ty and a source of resistin and visfatin [ J ]. Diabetologia, 2006,49 (~) :744 - 747.
10Moschen AR, Kaser A, Enrich B, et al. Visfatin, an adipocy- tokine with proinflammatory and immunomodulating proper- ties[ J 3. J Immuno1,2007,178 (3) : 1748 - 1758.
